Hematology NewsMM patients with concurrent AL show poor survival when coupled to cardiac dysfunctionJuly 23, 2020Multiple MyelomaMixed Topics
Hematology NewsTransitioning regimen may prolong proteasome inhibitor–based therapy for MMJuly 9, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsIsa-Kd improves PFS in relapsed/refractory multiple myelomaJune 24, 2020Multiple Myeloma
Hematology NewsTandem transplantation, long-term maintenance may extend MM remissionJune 11, 2020Multiple MyelomaTransplantMixed Topics
Hematology NewsVaccination regimen effective in preventing pneumonia in MM patientsMay 21, 2020Multiple MyelomaPreventive CareGI Oncology
Hematology NewsTransplant beats bortezomib-based therapy for MM, but questions remainMay 7, 2020Multiple Myeloma
Hematology NewsCombo therapy with melflufen promising in small r/r multiple myeloma studyApril 23, 2020Multiple MyelomaMixed Topics
Hematology NewsASH tackles COVID-19 with hematology-related FAQ, promotes new registriesApril 14, 2020COVID-19 UpdatesAnemiaMultiple MyelomaMyelodysplastic SyndromeT Cell Lymphomas
Hematology NewsFirst report of MM patient successfully treated for COVID-19 with tocilizumabApril 6, 2020COVID-19 UpdatesMultiple Myeloma
Oncology PracticeMaintaining cancer care in the face of COVID-19April 1, 2020COVID-19 UpdatesPatient & Survivor CareCNS/Brain CancerGastroenterologyGenitourinary CancerGI OncologyGynecologic Cancer
Hematology NewsMultiple myeloma treatment produces a similar survival benefit in very elderly patientsMarch 26, 2020Multiple Myeloma
Hematology NewsFracture risk for MM patients remains higher despite improvements in treatments, survivalMarch 12, 2020Multiple Myeloma
Hematology NewsStored CD34 cells for multiple myeloma patients largely unusedMarch 6, 2020Multiple MyelomaTransplant
Hematology NewsFDA approves new drug for relapsed/refractory multiple myelomaMarch 2, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
